TFRC and early-onset autosomal dominant Alzheimer disease: Instead, it may be advantageous that the BEC expression of the transferrin receptor remains unchanged in Alzheimer’s disease [85], which further justifies attempts to target transferrin receptors expressed by BECs in the neurodegenerative brain expected to have a near intact BBB.